| For: | Mbaga DS, Kenmoe S, Njiki Bikoï J, Takuissu GR, Amougou-Atsama M, Atenguena Okobalemba E, Ebogo-Belobo JT, Bowo-Ngandji A, Oyono MG, Magoudjou-Pekam JN, Kame-Ngasse GI, Nka AD, Feudjio AF, Zemnou-Tepap C, Adamou Velhima E, Ndzie Ondigui JL, Nayang-Mundo RA, Touangnou-Chamda SA, Kamtchueng Takeu Y, Taya-Fokou JB, Mbongue Mikangue CA, Kenfack-Momo R, Kengne-Ndé C, Sake CS, Esemu SN, Njouom R, Ndip L, Riwom Essama SH. Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis. World J Methodol 2022; 12(3): 179-190 [PMID: 35721241 DOI: 10.5662/wjm.v12.i3.179] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i3/179.htm |
| Number | Citing Articles |
| 1 |
Juliette Laure Ndzie Ondigui, Sebastien Kenmoe, Cyprien Kengne-Ndé, Jean Thierry Ebogo-Belobo, Guy Roussel Takuissu, Raoul Kenfack-Momo, Donatien Serge Mbaga, Serges Tchatchouang, Josiane Kenfack-Zanguim, Robertine Lontuo Fogang, Elisabeth Zeuko'o Menkem, Ginette Irma Kame-Ngasse, Jeannette Nina Magoudjou-Pekam, Arnol Bowo-Ngandji, Nadège Mafopa Goumkwa, Seraphine Nkie Esemu, Lucy Ndip, Sara Honorine Riwom Essama, Judith Torimiro. Epidemiology of occult hepatitis B and C in Africa: A systematic review and meta-analysis. Journal of Infection and Public Health 2022; 15(12) doi: 10.1016/j.jiph.2022.11.008
|
| 2 |
Robério Amorim de Almeida Pondé. Detection of anti-HCV antibodies in the clinical classification and epidemiological surveillance of HCV infection. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10827-2
|
| 3 |
I. A. Narkevich, E. A. Tsitlionok. Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 2023; 16(4) doi: 10.17749/2070-4909/farmakoekonomika.2023.193
|
| 4 |
Uzma Saleem, Nosheen Aslam, Rida Siddique, Shabnoor Iqbal, Maria Manan. Hepatitis C virus: Its prevalence, risk factors and genotype distribution in Pakistan. European Journal of Inflammation 2022; 20 doi: 10.1177/1721727X221144391
|
| 5 |
Sherif Elbaz, Nasser Mousa, Alaa Elmetwalli, Ahmed Abdel-Razik, Mohamed Salah, Amr ElHammady, Mostafa Abdelsalam, Eman Abdelkader, Niveen El-wakeel, Waleed Eldars, Ola El-Emam, Ahmed Elbeltagy, Mohamed Shaheen, Hossam El-Zamek, Eman Mousa, Ahmed Deiab, Ayman Elgamal, Alaa Habib. Unraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-024-09032-6
|
| 6 |
Luis Antonio Uribe-Noguez, María Erandhi Prieto-Torres, Luis Octavio Uribe-Noguez, José Antonio Mata-Marín, Carla Ileana Arroyo-Anduiza, Rebeca Paquentín-Jimenez, Alberto Chaparro-Sanchez, Wendy Guadalupe Vazquez-Gonzalez, Andrea Santos Coy-Arechavaleta, Ericka Nelly Pompa-Mera, Jesus Gaytán-Martínez, Julio Elias Alvarado-Yaah, Clara Esperanza Santacruz-Tinoco, Alicia Ocaña-Mondragón. Prevalence and Risk Factors of Occult HCV Infection in the Adult Population of Mexico City. Viruses 2025; 17(2) doi: 10.3390/v17020236
|
| 7 |
|
| 8 |
Liangying Gan, Dongdong Li, Yuanfang Wang, Yulan Shen, Sanhua Yan, Yanxia Liu, Daqing Hong, Junxia Wang, Jialiang Pang, Guohao Shan, Guiying Li, Haiying Zhang, Huiying Rao, Li Zuo, Binwu Ying, Elitza S. Theel. Diagnostic performance and clinical utility of an HCV antigen-antibody combination assay across diverse real-world cohorts. Journal of Clinical Microbiology 2026; doi: 10.1128/jcm.01201-26
|
| 9 |
Paulina Vidal-Cevallos, Nayelli Flores-García, Norberto C. Chávez-Tapia, Naga P. Chalasani. Occult liver disease: A multinational perspective. Annals of Hepatology 2024; 29(3) doi: 10.1016/j.aohep.2024.101480
|
| 10 |
Yamila Martín, Kelly Alejandra Ramírez Ladino, Guido López, Estela Outon, Cecilia María Delfino. Detection of seronegative occult hepatitis C infection in blood donors and hospital patients from Argentina. Virus Genes 2026; 62(2) doi: 10.1007/s11262-026-02223-0
|
| 11 |
Busara Songtanin, Jackeline Flores, Romelia Barba, Jowana Saba, Kenneth Nugent. Occult Hepatitis C Virus Infection: A Narrative Review. Journal of Viral Hepatitis 2025; 32(8) doi: 10.1111/jvh.70051
|